Tzu-Lung Lin

Title: Tzu-Lung Lin: Innovator in Serotyping and Restriction Endonucleases

Introduction

Tzu-Lung Lin is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the fields of molecular biology and genetics through his innovative patents. With a total of 2 patents, Lin's work focuses on improving methods for serotyping and developing novel restriction endonucleases.

Latest Patents

One of Lin's latest patents involves a method for identifying a serotype using specific polymerase chain reaction (PCR) primer sets. This method is designed according to a fragment of a capsular polysaccharide synthesis (cps) region to identify a K57 or a NTUH-N1 serotype. The NTUH-N1 serotype is a novel discovery that differs from the previously reported 77 serotypes. This PCR-based cps genotyping method addresses the issues of insufficient specificity and sensitivity found in conventional immune methods. It offers advantages such as rapidity and low cost, making it applicable in clinical diagnosis. Additionally, this method reduces the rate of unidentifiable strains.

Another significant patent by Lin is for a novel type II restriction endonuclease, known as HpyC1I. This enzyme recognizes a specific non-palindromic sequence of five oligonucleotides and cleaves DNA downstream of the recognition sequence. The cleavage results in a one-base protruding end at the 5'-end. While the recognition and cleavage site of HpyC1I is identical to the known restriction endonuclease BccI, its nucleotide and amino acid sequences differ from any other known restriction enzymes.

Career Highlights

Tzu-Lung Lin is affiliated with National Taiwan University, where he conducts his research and development work. His contributions to the field have been recognized for their innovative approaches and practical applications.

Collaborations

Lin has collaborated with notable colleagues, including Jin-Town Wang and Yi-Jiun Pan, further enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Tzu-Lung Lin's innovative work in serotyping and restriction endonucleases showcases his commitment to advancing molecular biology. His patents not only address existing challenges but also pave the way for future developments in clinical diagnostics and genetic research.